Spotlight Pathology, a UK-based healthtech company, has secured £1.4 million in funding to enhance its AI-powered software. This tool is designed to analyze digital pathology images, assisting clinicians in the faster and more accurate detection of blood cancers.

Faster Diagnosis Thanks to AI

Blood cancers pose a complex diagnostic challenge, often requiring multiple consultations among specialized pathologists. Delays in diagnosis can have serious consequences for patients. Spotlight Pathology's software integrates into existing clinical workflows, helping pathologists prioritize cases and make decisions more quickly, enabling patients to begin treatment sooner.

The Team and Next Steps

Spotlight Pathology was founded by Dr. Richard Byers, a Consultant Haematopathologist, and Dr. Martin Fergie, an AI specialist with over 15 years of experience in developing advanced algorithms for healthcare applications. The investment will support the company in obtaining further regulatory approvals and progressing through the first clinical in-use trials.